A randomized open-label trial on the use of budesonide/formoterol (Symbicort(®)) as an alternative reliever medication for mild to moderate asthmatic attacks

BACKGROUND: Conventionally, a nebulized short-acting β-2 agonist like salbutamol is often used as the reliever in acute exacerbations of asthma. However, recent worldwide respiratory outbreaks discourage routine use of nebulization. Previous studies have shown that combined budesonide/formoterol (Sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, Keng Sheng, Kamarudin, Hamizah, Hashim, Che Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352303/
https://www.ncbi.nlm.nih.gov/pubmed/22503137
http://dx.doi.org/10.1186/1865-1380-5-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352303/
https://www.ncbi.nlm.nih.gov/pubmed/22503137
http://dx.doi.org/10.1186/1865-1380-5-16

Ejemplares similares